Sunday, March 23, 2025
Home Ovarian Cancer Page 3

Ovarian Cancer

Phase II randomized study of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.
Ovarian Cancer

Phase II randomized study of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.

Dr Steve Vasilev MD -
0
I had 3 years to live after I was diagnosed with ovarian cancer
Ovarian Cancer

I had 3 years to live after I was diagnosed with ovarian cancer

Dr Steve Vasilev MD -
0
The study suggests that ovarian cancer cells adapt to their environment to support tumor growth
Ovarian Cancer

The study suggests that ovarian cancer cells adapt to their environment to support tumor growth

Dr Steve Vasilev MD -
0
primary peritoneal carcinoma
Peritoneal Cancer

Primary peritoneal carcinoma

Dr Steve Vasilev MD -
0
Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact
Survival

Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact

Dr Steve Vasilev MD -
0
123Page 3 of 3
© Newspaper WordPress Theme by TagDiv